Close Menu

NEW YORK (GenomeWeb News) – Dako today announced a project with Amgen to develop a companion diagnostic test using Dako's IQFISH hybridization buffer.

The buffer was introduced by Dako, an Agilent company, in 2012 and allows pathology laboratories to run DNA-based hybridization assays "with distinct and higher fluorescent signal intensity compared to traditional FISH assays," Dako said, adding IQFISH reduces diagnostic turnaround time to 3.5 hours from 17 hours.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.

US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.

The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.

In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.

May
06
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.